Carregant...
Hematopoietic stem cell transplantation in the era of engineered cell therapy.
PURPOSE OF REVIEW: Cellular therapy using T cells modified to express chimeric antigen receptors (CAR-T cells) has had striking success in patients that have failed previous treatment for CD19+ B cell non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL) or acute lymphoblastic leukemia (ALL...
Guardat en:
| Publicat a: | Curr Hematol Malig Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6333424/ https://ncbi.nlm.nih.gov/pubmed/30280289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-018-0476-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|